Dexcom’s G7 just received CE Mark approval in Europe, with a limited launch expected in the coming weeks. Abbott’s FreeStyle Libre 3 has been available in parts of Europe already, but it is now available for use via the NHS Supply Chain Framework in the UK and under existing eligibility criteria for real-time CGM. Here are the highlights of both systems.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/03/dexcom-g7-gets-the-green-light-in-europe-and-freestyle-libre-3-available-via-nhs-in-the-uk/" align="left"]The FDA recently cleared Insulet’s Omnipod 5, the first and only tubeless automated insulin delivery (AID) system in the U.S. with compatible smartphone control and Dexcom G6 CGM integration.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/01/the-omnipod-5-is-finally-approved/" align="left"]Continuous glucose monitoring (CGM) is an awesome technology, but it’s not perfect. Here are some tips on how to deal with the challenges many of us face, from lost signals to skin irritation.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/08/troubleshooting-tips-for-cgm/" align="left"]When you don’t feel well due to high or low blood sugars, it’s hard to be your best. That’s why it’s so important to know about time in range and what it can do for your mental and physical health. Dr. Polonsky delves into the details and shares how time in range impacts all areas of your life.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/07/how-does-time-in-range-affect-quality-of-life/" align="left"]In this Facebook Live, Dr. E and Dr. B talk all things CGM. They give an overview of the CGMs on the market today, they explain the features, benefits, pros and cons, and they answer viewer questions on the spot.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/05/facebook-live-everything-you-need-to-know-about-cgms/" align="left"]




